2025³â 08¿ù 08ÀÏ ±Ý¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > Àαⴺ½º

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
 
¸ðµÎ 92606°³ÀÇ ´º½º°¡ °Ë»öµÇ¾ú½À´Ï´Ù.



GS25 ¡®»ý°úÀÏ ½º¹«µð¡¯ ¿î¿µÁ¡ ±âÁØ Àüü ÆÇ¸Å·® 3À§

2030 ¼¼´ë°¡ °í°´ 69.5%
GS25°¡ ¾÷°è ÃÖÃÊ·Î ¼±º¸ÀÎ »ý°úÀÏ ½º¹«µð Àü¿ë ±â±â GS¸®Å×ÀÏÀÌ ¿î¿µÇÏ´Â ÆíÀÇÁ¡ GS25°¡ º»°ÝÀûÀÎ ¹«´õÀ§¸¦ ¸Â¾Æ ÃÖ±Ù 2ÁÖ°£(6/23~7/6) ‘»ý°úÀÏ ½º¹«µð’ ¿î¿µ Á¡Æ÷ 20¿© °÷À» ´ë»óÀ¸·Î ÆÇ¸Å µ¥ÀÌÅ͸¦ ºÐ¼®ÇÑ °á°ú »ý°úÀÏ ½º¹«µð°¡ ‘Ä«Æä25 ¾Æ¸Þ¸®Ä«³ë’, ‘ÄÅ ¾óÀ½’¿¡ À̾î Àüü ÆÇ¸Å·® 3À§(´ã¹è Á¦¿Ü)¿¡ µî±ØÇÑ °ÍÀ¸·Î ºÐ¼®µÆ´Ù. GS25´Â Áö³­ÇØ 12¿ù ÆíÀÇÁ¡ ¾÷°è ÃÖÃÊ·Î Á÷¿µÁ¡ ÇѰ÷À» ÅëÇØ Áï¼® »ý°úÀÏ ½º¹«µð¸¦ ¼±º¸¿´´Ù. ÃֽŠ¸Ô°Å¸® Æ®·»µå¸¦ ¼±Á¡ÇϰíÀÚ ÆíÀÇÁ¡ Ư¼º¿¡ ¸Â´Â Àü¿ë ±â±â ...

¡®±ñdzġŲ »À ¹ß¶ó¹ö¸± ¹ß°ñ Àü¹®°¡¡¯ ¸ðÁý¡¦ÀÏ±Þ 100¸¸¿ø

ÀâÄÚ¸®¾Æx¾Ë¹Ù¸óxǪ¶ó´ß º¹³¯ ÀÌ»ö¾Ë¹Ù
ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸ó(´ëÇ¥ÀÌ»ç À±ÇöÁØ)ÀÌ º¹³¯À» ¸Â¾Æ ġŲ Àü¹® ºê·£µå Ǫ¶ó´ß ġŲ°ú ÇÔ²² ÀÌ»ö ¾Ë¹Ù¸¦ ¸ðÁýÇÏ´Â À̺¥Æ®¸¦ ÁøÇàÇÑ´Ù°í 21ÀÏ ¹àÇû´Ù. ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸óÀº ³»´Þ 3ÀϱîÁö Ǫ¶ó´ß ġŲ°ú Çù¾÷ÇØ º¹³¯ ±â³ä ÀÌ»ö °ø°í¸¦ ³»°í ‘±ñdzġŲ »À ¹Ù¸¦ ¾Ë¹Ù¸ó’°ú ‘±ñdzġŲ »À ¹ß¶ó¹ö¸± ¹ß°ñ Àü¹®°¡’¸¦ ¸ðÁýÇÑ´Ù. À̹ø À̺¥Æ®´Â ¾Ë¹Ù¸óÀÌ ÁøÇà ÁßÀÎ ´ë±Ô¸ð ÇÁ·Î¸ð¼Ç ‘2025 ¿©¸§ ¾Ë¹Ù Æä½ºÅ¸(¿©¾ËÆä)’ÀÇ ÀÏȯÀÌ´Ù. ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸óÀº ¿©¸§Ã¶ ¹«´õÀ§¿Í ²ß²ßÇÑ ³¯¾¾·Î ÁöÃÄ ÀÖ´Â ±¸Á÷ÀÚµéÀ» À§ ...

Novotech Report: How In-Vivo CAR-T May Reshape Cell Therapy Econo...
SYDNEY -- With in-vivo CAR-T therapies gaining global momentum, a new whitepaper from Novotech, a leading global full-service clinical Contract Research Organization (CRO) and scientific advisory company, offers insight into this next frontier of immunotherapy. In-Vivo CAR Therapies - Global Research and Development Landscape (2025) report explores the accelerating innovation in in-vivo CAR-T (Chimeric Antigen Receptor) technologies and their potential to reshape treatment across oncology, autoi ...
3D ¸ð¼Ç ¼Ö·ç¼Ç ¡®¹«¹ö½º¡¯ ÇØ¿Ü ½ÃÀå °Ü³ÉÇÑ´Ù (2023-07-09)
Citi Unifies Global Wealth Management Business (2021-01-14)
½Å¼¼°è±×·ì, 2018 »ó»ý ä¿ë ¹Ú¶÷ȸ °³ÃÖ (2018-03-18)
Áö¿ª ¹®Á¦ ÇØ°á À§ÇØ ¹Î¡¤°ü Çù·Âü°è ±¸Ãà (2022-06-06)
LIG³Ø½º¿ø, 2022³â ¡®Á¦´ë±ºÀÎ °í¿ë ¿ì¼ö±â¾÷¡¯ ¼±Á¤ (2022-10-11)
SKÅÚ·¹ÄÞ, LGÆú´õ 2¿¡ AIºñ¼­ ¡®´©±¸¡¯ žÀç (2020-04-18)
°°Àº ¡®È­ÀÌÆ®+¹ö°Çµð¡¯ ´Ù¸¥ ´À³¦ (2014-12-10)
½´³ªÀÌ´õ ÀÏ·ºÆ®¸¯, Ú¸ ȯ°æÃ» ¿¡³ÊÁö½ºÅ¸»ó (2021-05-04)
Àü±âÂ÷ ÇöÀç 1À§ Ú¸, 5³âÈÄ 1À§ ùÛ, ÃÖ´ë À§Çù ñé (2023-06-22)
ÀÚµ¿Â÷ Æ©´×¼ÒÀ½±â ÀÎÁõ ±âÁØ °³¼± (2022-01-13)
³» ¸¶À½´ë·Î ÄÚµðÇÏ´Â DIYÇü ¾Æ¿ìÅÍ º¿¹° (2019-11-09)
LGÀüÀÚ, ÀΰøÁö´É Ç÷§Æû µö¾ÅÅ¥ 2.0 ¹èÆ÷ (2018-10-07)
´ºÀ̽ºÆ® ¹ÎÇö, ¼Ò¹®³­ ²ÜÇǺΠºñ°á (2021-08-22)
ù ¶óÀξ÷ ¡®¾à°úµµ³Ó¡¤¾à°úÄÅÄÉÀÌÅ©¡¯ ¼±ºÄ (2023-06-05)
±¹³» ¿Â¶óÀÎ ¼îÇθô ¸ÅÃâ 136% ´Ã¾î (2018-12-22)
±â¾ÆÂ÷, UEFA À¯·ÎÆÄ ¸®±× ÈÄ¿ø ü°á (2018-03-09)
¾Æ¿ôµµ¾î ãæ È¿ÀÚ¾ÆÀÌÅÛ '½Å¹ß' (2020-05-30)
±³À°ºÎ, Àü±¹ »ç¸³´ëÇÐ ÀÔÇÐ±Ý ÆóÁö È®Á¤ (2018-02-20)
Çö´ëÀÚµ¿Â÷, ´õ ´º ¾Æ¹Ý¶¼ ½ºÆ÷Ã÷ Ãâ½Ã (2018-11-01)
SKT, ±¹ÅäºÎ UAM ½ÇÁõ Áö¿ø 5G »ó°ø¸Á ±¸Ãà (2022-08-04)
Humanigen Initiates Submission for Lenzilumab Marketing Auth... (2021-06-15)
Á¦³×½Ã½º GV70, ¸ðÅÍÆ®·»µå ¡®¿ÃÇØÀÇ SUV¡¯ ¼±Á¤ (2021-10-20)
Chungcheongbuk-do to Host the 2021 Online World Martial Arts... (2021-10-20)
°Ü¿ïö ±ØÇѾ˹٠1À§ ¡®Åùè»óÇÏÂ÷¡¯ (2021-01-05)
¼öÀÔÂ÷ 20% ¿À¸¦ ¶§ ±¹»êÂ÷ 30% ¿Ã¶ú´Ù (2021-01-05)
       [ÀÌÀü][1]....[2608][2609][2610][2611][2612][2613][2614][2615][2616]...[3705][´ÙÀ½]

°øÁö»çÇ×
´º½ºÁö ÇÑÀÚ Ç¥±â¿¡ ´ë¸¸½Ä À½Â÷ Ç¥±â '纽ÞÙó¢ ´Ï¿ì½ÃÁö' º´±â
º£³×ÇÁ·Ò º£³×ÀÎÅõ Áß¹® Ç¥±â 宝Ò¬ÜØÙÌ 宝Ò¬ì×öõ(ÜÄÒ¬ÜØÙÌ ÜÄ...
¹Ìµð¾î¾Æ¿ì¾î Mediaour ØÚ体ä²们 ØÚô÷ä²Ùú MO ¿¥¿À ØÚä² ØÚä²
¾Ë¸®¿ìºê Alliuv ä¹备: ä¹联êó备, ¾Ë¶ã Althle ä¹÷åìÌ
¾Ë¸®¾Ë Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º : À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¹ÙÀÌ¿ÀÀÌ´Ï Bioini Áß¹® Ç¥±â ù±药研 ù±å·æÚ
¿À½ºÇÁ·Ò Ausfrom 奥ÞÙÜØÙÌ, À£ÇÁ·Ò Welfrom 卫ÜØÙÌ
¿¡³ÊÇÁ·Ò Enerfrom 额ÒöÜØÙÌ ¿¡³ÊÀ¯ºñ Eneruv 额Òöêó备
¾ËÇÁ·Ò Alfrom Áß¹® Ç¥±â ä¹尔ÜØÙÌ ä¹ì³ÜØÙÌ
 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..